{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:53:09Z","timestamp":1777870389696,"version":"3.51.4"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T00:00:00Z","timestamp":1560988800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T00:00:00Z","timestamp":1560988800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100006595","name":"Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii","doi-asserted-by":"publisher","award":["II-RU-TE-2014-4-0151"],"award-info":[{"award-number":["II-RU-TE-2014-4-0151"]}],"id":[{"id":"10.13039\/501100006595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s40620-019-00621-2","type":"journal-article","created":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T05:02:30Z","timestamp":1561006950000},"page":"91-100","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Differential methylation pattern of xenobiotic metabolizing genes and susceptibility to Balkan endemic nephropathy, in a cohort of Romanian patients"],"prefix":"10.1093","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9394-3419","authenticated-orcid":false,"given":"Alexandra","family":"Ivan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilys","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirabela Iustina","family":"Cristea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ada","family":"Telea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra Teodora","family":"Gruia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camelia","family":"Oprean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florin","family":"Margineanu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florina Maria","family":"Bojin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Saffery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virgil","family":"Paunescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Calin Adrian","family":"Tatu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,6,20]]},"reference":[{"issue":"3","key":"621_CR1","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/ckj\/sft049","volume":"6","author":"NM Pavlovi\u0107","year":"2013","unstructured":"Pavlovi\u0107 NM (2013) Balkan endemic nephropathy\u2014current status and future perspectives. Clin Kidney J 6(3):257\u2013265. \nhttps:\/\/doi.org\/10.1093\/ckj\/sft049","journal-title":"Clin Kidney J"},{"issue":"3","key":"621_CR2","first-page":"390","volume":"17","author":"IE Andonova","year":"2004","unstructured":"Andonova IE, Sarueva RB, Horvath AD, Simenov VA, Dimitrov PS, Petropoulos EA et al (2004) Balkan endemic nephropathy and genetic variants of glutathione S transferases. J Nephrol 17(3):390\u2013398","journal-title":"J Nephrol"},{"key":"621_CR3","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/1471-2369-14-225","volume":"14","author":"R Staneva","year":"2013","unstructured":"Staneva R, Rukova B, Hadjidekova S, Nesheva D, Antonova O, Dimitrov P et al (2013) Whole genome methylation array analysis reveals new aspects in Balkan endemic nephropathy etiology. BMC Nephrol 14:225. \nhttps:\/\/doi.org\/10.1186\/1471-2369-14-225","journal-title":"BMC Nephrol"},{"key":"621_CR4","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s10653-017-0065-9","volume":"40","author":"AT Gruia","year":"2018","unstructured":"Gruia AT, Oprean C, Ivan A, Cean A, Cristea M, Draghia L et al (2018) Balkan endemic nephropathy and aristolochic acid I: an investigation into the role of soil and soil organic matter contamination, as a potential natural exposure pathway. Environ Geochem Health 40:1437\u20131448. \nhttps:\/\/doi.org\/10.1007\/s10653-017-0065-9","journal-title":"Environ Geochem Health"},{"key":"621_CR5","volume-title":"Biomedical & biopharmaceutical sciences with patient care correlations","author":"R Karimi","year":"2015","unstructured":"Karimi R (2015) Biomedical & biopharmaceutical sciences with patient care correlations. Jhons Bartlett Learning, Burlington"},{"issue":"4","key":"621_CR6","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/bcp.12086","volume":"76","author":"KP Knights","year":"2013","unstructured":"Knights KP (2013) Renal drug metabolism in humans: the potential for drug\u2013endobiotic interactions involving cytochrome P450 (CYP) and UDPglucuronosyltransferase (UGT). Brit J Clin Pharmacol 76(4):587\u2013602. \nhttps:\/\/doi.org\/10.1111\/bcp.12086","journal-title":"Brit J Clin Pharmacol"},{"key":"621_CR7","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s11255-011-0082-z","volume":"44","author":"B Chen","year":"2012","unstructured":"Chen B, Bai Y, Sun M, Ni X, Yang Y et al (2012) Glutathione S-transferases T1 null genotype is associated with susceptibility to aristolochic acid nephropathy. Int Urol Nephrol 44:301\u2013307. \nhttps:\/\/doi.org\/10.1007\/s11255-011-0082-z","journal-title":"Int Urol Nephrol"},{"issue":"4","key":"621_CR8","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/BF01797915","volume":"14","author":"DM Grant","year":"1991","unstructured":"Grant DM (1991) Detoxification pathways in the liver. J Inherit Metab Dis 14(4):421\u2013430","journal-title":"J Inherit Metab Dis"},{"key":"621_CR9","doi-asserted-by":"publisher","first-page":"E4","DOI":"10.1017\/S1462399411002110","volume":"14","author":"X Gu","year":"2012","unstructured":"Gu X, Manautou J (2012) Molecular mechanisms underlying chemical liver injury. Expert Rev Mol Med 14:E4. \nhttps:\/\/doi.org\/10.1017\/S1462399411002110","journal-title":"Expert Rev Mol Med"},{"issue":"3","key":"621_CR10","first-page":"384","volume":"7","author":"DI Toncheva","year":"2004","unstructured":"Toncheva DI, Von Ahsen N, Atanasova SY, Dimitrov TG, Armstrong VW, Oellerich M (2004) Identification of NQO1 and GSTs genotype frequencies in Bulgarian patients with Balkan endemic nephropathy. J Nephrol 7(3):384\u2013389","journal-title":"J Nephrol"},{"key":"621_CR11","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/tpj.2009.4","volume":"9","author":"R Ghotbi","year":"2009","unstructured":"Ghotbi R, Gomez A, Milani L, Tybring G, Syv\u00e4nen AC, Bertilsson L et al (2009) Allele-specific expression and gene methylation in the control of CYP1A2 mRNA level in human livers. Pharmacogenom J 9:208\u2013217","journal-title":"Pharmacogenom J"},{"key":"621_CR12","doi-asserted-by":"publisher","first-page":"e119","DOI":"10.1093\/nar\/gkm662","volume":"35","author":"MW Coolen","year":"2007","unstructured":"Coolen MW, Statham AL, Gardiner-Garden M, Clark SJ (2007) Genomic profiling of CpG methylation and allelic specificity using quantitative high-throughput mass spectrometry: critical evaluation and improvements. Nucleic Acids Res 35:e119. \nhttps:\/\/doi.org\/10.1093\/nar\/gkm662","journal-title":"Nucleic Acids Res"},{"key":"621_CR13","doi-asserted-by":"publisher","first-page":"R42","DOI":"10.1186\/gb-2013-14-5-r42","volume":"14","author":"D Martino","year":"2013","unstructured":"Martino D, Loke YJ, Gordon L, Ollikainen M, Cruickshank MN, Saffery R et al (2013) Longitudinal, genome-scale analysis of DNA methylation in twins from birth to 18\u00a0months of age reveals rapid epigenetic change in early life and pair-specific effects of discordance. Genome Biol 14:R42. \nhttps:\/\/doi.org\/10.1186\/gb-2013-14-5-r42","journal-title":"Genome Biol"},{"issue":"6","key":"621_CR14","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1124\/dmd.106.013979","volume":"35","author":"W Chan","year":"2007","unstructured":"Chan W, Luo HB, Zheng Y, Cheng YK, Cai Z (2007) Investigation of the metabolism and reproductive activation of carcinogenic aristolochic acids in rats. Drug Metab Dispos 35(6):866\u2013874. \nhttps:\/\/doi.org\/10.1124\/dmd.106.013979","journal-title":"Drug Metab Dispos"},{"issue":"10","key":"621_CR15","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.3390\/ijms18102144","volume":"18","author":"M Stiborov\u00e1","year":"2017","unstructured":"Stiborov\u00e1 M, Arlt VM, Schmeiser HH (2017) DNA adducts formed by aristolochic acid are unique biomarkers of exposure and explain the initiation phase of upper urothelial cancer. Int J Mol Sci 18(10):2144. \nhttps:\/\/doi.org\/10.3390\/ijms18102144","journal-title":"Int J Mol Sci"},{"issue":"1","key":"621_CR16","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/13102818.2004.10819237","volume":"18","author":"S Atanasova","year":"2004","unstructured":"Atanasova S, von Ahsen N, Dimitrov T, Oellerich M, Toncheva D (2004) First study of NATl and NAT2 polymorphisms in bulgarian patients with Balkan endemic nephropathy (BEN) and healthy controls. Biotechnol Biotechnol Equip 18(1):95\u2013103. \nhttps:\/\/doi.org\/10.1080\/13102818.2004.10819237","journal-title":"Biotechnol Biotechnol Equip"},{"key":"621_CR17","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/ijc.10602","volume":"101","author":"VM Arlt","year":"2002","unstructured":"Arlt VM, Ferluga D, Stiborova M, Pfohl-Leszkowicz A, Vukelic M, Vdovic S et al (2002) Is aristolochic acid a risk factor for Balkan endemic nephropathy-associated urothelial cancer? Int J Cancer 101:500\u2013502. \nhttps:\/\/doi.org\/10.1002\/ijc.10602","journal-title":"Int J Cancer"},{"key":"621_CR18","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.taap.2007.09.017","volume":"226","author":"M Stiborov\u00e1","year":"2008","unstructured":"Stiborov\u00e1 M, Arlt VM, Henderson CJ, Wolf CR, Kotrbov\u00e1 V, Moserov\u00e1 M et al (2008) Role of hepatic cytochromes P450 in bioactivation of the anticancer drug ellipticine: studies with the hepatic NADPH:cytochrome P450 reductase null mouse. Toxicol Appl Pharmacol 226:318\u2013327. \nhttps:\/\/doi.org\/10.1016\/j.taap.2007.09.017","journal-title":"Toxicol Appl Pharmacol"},{"issue":"11","key":"621_CR19","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1007\/s00204-016-1819-3","volume":"90","author":"M Stiborov\u00e1","year":"2016","unstructured":"Stiborov\u00e1 M, Arlt VM, Schmeiser HH (2016) Balkan endemic nephropathy: an update on its aetiology. Arch Toxicol 90(11):2595\u20132615. \nhttps:\/\/doi.org\/10.1007\/s00204-016-1819-3","journal-title":"Arch Toxicol"},{"key":"621_CR20","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1093\/carcin\/23.4.617","volume":"23","author":"M Stiborova","year":"2002","unstructured":"Stiborova M, Frei E, Sopko B, Wiessler M, Schmeiser HH (2002) Carcinogenic aristolochic acids upon activation by DT-diaphorase form adducts found in DNA of patients with Chinese herbs nephropathy. Carcinogenesis 23:617\u2013625. \nhttps:\/\/doi.org\/10.1093\/carcin\/23.4.617","journal-title":"Carcinogenesis"},{"key":"621_CR21","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1093\/carcin\/bgg119","volume":"24","author":"M Stiborova","year":"2003","unstructured":"Stiborova M, Frei E, Sopko B, Sopkova K, Markova V, Lankova M et al (2003) Human cytosolic enzymes involved in the metabolic activation of carcinogenic aristolochic acid: evidence for reductive activation by human NAD(P)H: quinone oxidoreductase. Carcinogenesis 24:1695\u20131703. \nhttps:\/\/doi.org\/10.1093\/carcin\/bgg119","journal-title":"Carcinogenesis"},{"issue":"6","key":"621_CR22","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/em.20642","volume":"52","author":"M Stiborov\u00e1","year":"2011","unstructured":"Stiborov\u00e1 M, Mare\u00ees J, Frei E, Volker M, Arlt VM, Heinz HS (2011) The human carcinogen aristolochic acid I is activated to form DNA adducts by human NAD(P)H:quinone oxidoreductase without the contribution of acetyltransferases or sulfotransferases. Environ Mol Mutagen 52(6):448\u2013459. \nhttps:\/\/doi.org\/10.1002\/em.20642","journal-title":"Environ Mol Mutagen"},{"issue":"12","key":"621_CR23","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1055\/s-0029-1185685","volume":"75","author":"SB Lee","year":"2009","unstructured":"Lee SB, Kim CY, Lee HJ, Yun JH, Nho CW (2009) Induction of the phase II detoxification enzyme NQO1 in hepatocarcinoma cells by lignans from the fruit of Schisandra chinensis through nuclear accumulation of Nrf2. Planta Med 75(12):1314\u20131318. \nhttps:\/\/doi.org\/10.1055\/s-0029-1185685","journal-title":"Planta Med"},{"issue":"10","key":"621_CR24","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.3390\/ijms18102144","volume":"18","author":"M Stiborov\u00e1","year":"2017","unstructured":"Stiborov\u00e1 M, Volker M, Arlt VM, Heinz H, Schmeiser HH (2017) DNA adducts formed by aristolochic acid are unique biomarkers of exposure and explain the initiation phase of upper urothelial cancer. Int J Mol Sci 18(10):2144. \nhttps:\/\/doi.org\/10.3390\/ijms18102144","journal-title":"Int J Mol Sci"},{"issue":"6","key":"621_CR25","doi-asserted-by":"publisher","first-page":"e99448","DOI":"10.1371\/journal.pone.0099448","volume":"9","author":"MG Matic","year":"2017","unstructured":"Matic MG, Coric VM, Savic-Radojevic AR, Bulat PV, Pljesa-Ercegovac MS et al (2017) Does occupational exposure to solvents and pesticides in association with glutathione S-transferase A1, M1, P1, and T1 polymorphisms increase the risk of bladder cancer? The Belgrade Case\u2013Control Study. PLoS ONE 9(6):e99448. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0099448","journal-title":"PLoS ONE"},{"key":"621_CR26","first-page":"131","volume-title":"Pharmacology principles and practice","author":"K Bachmann","year":"2009","unstructured":"Bachmann K (2009) Drug metabolism. In: Hacker M, Messer WS II, Bachmann KA (eds) Pharmacology principles and practice. Academic Press, Cambridge, pp 131\u2013173"},{"key":"621_CR27","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1002\/ijc.21714","volume":"118","author":"EM Kellen","year":"2006","unstructured":"Kellen EM, Zeegers A, Paulussen M, Van Dongen M, Buntinx F et al (2006) Fruit consumption reduces the effect of smoking on bladder cancer risk. The Belgian case control study on bladder cancer. Int J Cancer 118:2572\u20132578","journal-title":"Int J Cancer"},{"key":"621_CR28","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1093\/aje\/kwj321","volume":"164","author":"S Raimondi","year":"2006","unstructured":"Raimondi S, Paracchini V, Autrup H, Barros-Dios JM, Benhamou S, Boffetta P et al (2006) Meta- and pooled analysis of GSTT1 and lung cancer: a HuGE-GSEC review. Am J Epidemiol 164:1027\u20131042. \nhttps:\/\/doi.org\/10.1093\/aje\/kwj321","journal-title":"Am J Epidemiol"},{"key":"621_CR29","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/j.1349-7006.2006.00207.x","volume":"97","author":"M Saadat","year":"2006","unstructured":"Saadat M (2006) Genetic polymorphisms of glutathione S-transferase T1 (GSTT1) and susceptibility to gastric cancer: a meta-analysis. Cancer Sci 97:505\u2013509","journal-title":"Cancer Sci"},{"key":"621_CR30","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.ejca.2005.01.014","volume":"41","author":"Z Ye","year":"2005","unstructured":"Ye Z, Song H (2005) Gluthatione S-transferase polymorphism (GSTM1, TESTP1 and GSTT) and risk of acute leukemia: a systemic review of meta-analysis. Eur J Cancer 41:980\u2013989. \nhttps:\/\/doi.org\/10.1016\/j.ejca.2005.01.014","journal-title":"Eur J Cancer"},{"issue":"8","key":"621_CR31","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.3390\/toxins6082348","volume":"6","author":"Z Reljic","year":"2013","unstructured":"Reljic Z, Zlatovic M, Savic-Radojevic A, Pekmezovic T, Djukanovic L, Matic M et al (2013) Is increased susceptibility to balkan endemic nephropathy in carriers of common GSTA1 (*A\/*B) polymorphism linked with the catalytic role of GSTA1 in ochratoxin A biotransformation? Serbian case control study and in silico analysis. Toxins (Basel) 6(8):2348\u20132362. \nhttps:\/\/doi.org\/10.3390\/toxins6082348","journal-title":"Toxins (Basel)"},{"key":"621_CR32","first-page":"25","volume":"240","author":"M Matic","year":"2016","unstructured":"Matic M, Dragicevic B, Pekmezovic T, Suvakov S, Savic-Radojevic A, Pljesa-Ercegovac M, Dragicevic D, Smiljic J, Simic T (2016) Common polymorphisms in GSTA1, GSTM1 and GSTT1 are associated with susceptibility to urinary bladder cancer in individuals from Balkan endemic nephropathy areas of Serbia, Tohoku. J Exp Med 240:25\u201330","journal-title":"J Exp Med"},{"key":"621_CR33","doi-asserted-by":"publisher","first-page":"34989","DOI":"10.1038\/srep34989","volume":"66","author":"HZ Amenya","year":"2016","unstructured":"Amenya HZ, Chiharu T, Seiichiroh O (2016) Dioxin induces Ahr-dependent robust DNA demethylation of the Cyp1a1 promoter via Tdg in the mouse liver. Sci Rep 66:34989. \nhttps:\/\/doi.org\/10.1038\/srep34989","journal-title":"Sci Rep"},{"key":"621_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/7943495","volume":"16","author":"C Dietrich","year":"2016","unstructured":"Dietrich C (2016) Antioxidant functions of the aryl hydrocarbon receptor. Stem Cell Int 16:1\u201310. \nhttps:\/\/doi.org\/10.1155\/2016\/7943495","journal-title":"Stem Cell Int"},{"issue":"8","key":"621_CR35","first-page":"730","volume":"11","author":"N Sunaga","year":"2002","unstructured":"Sunaga N, Kohno T, Yanagitani N, Sugimura H, Kunitoh H, Tamura T et al (2002) Contribution of the NQO1 and GSTT1 polymorphisms to lung adenocarcinoma susceptibility. Cancer Epidemiol Biomark Prev 11(8):730\u2013738","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"621_CR36","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S1383-5742(99)00005-8","volume":"436","author":"M Taningher","year":"1999","unstructured":"Taningher M, Malacarne D, Izzotti A, Ugolini D, Parodi S (1999) Drug metabolism polymorphisms as modulators of cancer susceptibility. Mutat Res 436:227\u2013261. \nhttps:\/\/doi.org\/10.1016\/S1383-5742(99)00005-8","journal-title":"Mutat Res"},{"key":"621_CR37","first-page":"3","volume":"9","author":"H Bartsch","year":"2000","unstructured":"Bartsch H, Nair U, Risch A, Rojas M, Wikman H, Alexandrov K (2000) Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomark Prev 9:3\u201328","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"621_CR38","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1093\/carcin\/15.2.415","volume":"15","author":"M Kihara","year":"1994","unstructured":"Kihara M, Noda K (1994) Lung cancer risk of GSTM1 null genotype is dependent on the extent of tobacco smoke exposure. Carcinogenesis (Lond) 15:415\u2013418","journal-title":"Carcinogenesis (Lond)"},{"key":"621_CR39","first-page":"733","volume":"6","author":"TR Rebbeck","year":"1997","unstructured":"Rebbeck TR (1997) Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomark Prev 6:733\u2013743","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"621_CR40","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1111\/j.1349-7006.1992.tb01992.x","volume":"83","author":"S Hayashi","year":"1992","unstructured":"Hayashi S, Watanabe J, Kawajiri K (1992) High susceptibility to lung cancer analyzed in terms of combined genotypes of P450IA1 and Mu-class glutathione S-transferase genes. Jpn J Cancer Res 83:866\u2013870","journal-title":"Jpn J Cancer Res"},{"key":"621_CR41","first-page":"4858","volume":"58","author":"L Le Marchand","year":"1998","unstructured":"Le Marchand L, Sivaraman L, Pierce L, Seifried A, Lum A, Wilkens LR et al (1998) Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens. Cancer Res 58:4858\u20134863","journal-title":"Cancer Res"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-019-00621-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40620-019-00621-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-019-00621-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:56:35Z","timestamp":1777564595000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/33\/1\/91\/8328486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,20]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["621"],"URL":"https:\/\/doi.org\/10.1007\/s40620-019-00621-2","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,20]]},"assertion":[{"value":"12 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Alexandra Ivan, Dilys Lam, Mirabela Iustina Cristea, Ada Telea, Alexandra Teodora Gruia, Camelia Oprean, Florin Margineanu, Florina Maria Bojin, Richard Saffery, Virgil Paunescu, and Calin Adrian Tatu declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the Ethical Committee for scientific research approval of the County Hospital \u201cPius Branzeu\u2019 Timisoara, Romania and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All participants gave their written informed consent for sample collection and publication of the data included in this case report study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent for publication"}}]}}